A Truncated Six Transmembrane Splice Variant MOR-1G Enhances Expression of the Full-Length Seven Transmembrane μ-Opioid Receptor through Heterodimerization

被引:16
|
作者
Zhang, Tiffany [1 ,2 ]
Xu, Jin [1 ,2 ]
Pan, Ying-Xian [1 ,2 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Neurol, 1275 York Ave, New York, NY 10065 USA
[2] Mem Sloan Kettering Canc Ctr, Mol Pharmacol & Chem Program, New York, NY 10065 USA
基金
美国国家卫生研究院;
关键词
SINGLE-NUCLEOTIDE POLYMORPHISM; CARBOXY-TERMINUS; N-GLYCOSYLATION; PROTEIN; ANALGESIA; ALTERS; MOUSE; GENE; INTERNALIZATION; IDENTIFICATION;
D O I
10.1124/mol.120.119453
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The mu-opioid receptor gene undergoes extensive alternative splicing to generate an array of splice variants. One group of splice variants excludes the first transmembrane (TM) domain and contains six TM domains. These 6TM variants are essential for the action of a novel class of analgesic drugs, including 3-iodobenzoyl-6 beta-naltrexannide, which is potent against a spectrum of pain models without exhibiting the adverse side effects of traditional opiates. The 6TM variants are also involved in analgesic action through other drug classes, including delta-opioid and kappa-opioids and alpha(2)-adrenergic drugs. Of the five 6TM variants in mouse, mouse mu-opioid receptor (nnMOR)-1G is abundant and conserved from rodent to human. In the present study, we demonstrate a new function of mMOR-1G in enhancing expression of the full-length 7TM mu-opioid receptor, mMOR-1. When coexpressed with mMOR-1 in a Tet-Off inducible CHO cell line, mMOR-1G has no effect on mMOR-1 mRNA expression but greatly increases mMOR-1 protein expression in a dose-dependent manner determined by opioid receptor binding and [S-35] guanosine 5'-3-O-(thio)triphosphate binding. Subcellular fractionation analysis using OptiPrep density gradient centrifugation shows an increase of functional mMOR-1 receptor in plasma membrane-enriched fractions. Using a coimmunoprecipitation approach, we further demonstrate that nnMOR-1G physically associates with mMOR-1 starting at the endoplasmic reticulum, suggesting a chaperone-like function. These data provide a molecular mechanism for how m MOR-1G regulates expression and function of the full-length 7TM mu-opioid receptor. SIGNIFICANCE STATEMENT The current study establishes a novel function of mouse mu-opioid receptor (nnMOR)-1G, a truncated splice variant with six transmembrane (TM) domains of the mouse mu-opioid receptor gene, in enhancing expression of the full-length 7TM mMOR-1 through a chaperone-like function.
引用
收藏
页码:518 / 527
页数:10
相关论文
共 4 条
  • [1] Enhanced expression of the full-length seven transmembrane mu opioid receptor by MOR-1G, a truncated six transmembrane splice variants through heterodimerization
    Zhang, Tiffany
    Xu, Jin
    Pan, Ying-Xian
    FASEB JOURNAL, 2020, 34
  • [2] Mu Opioids Induce Biased Signaling at the Full-Length Seven Transmembrane C-Terminal Splice Variants of the mu Opioid Receptor Gene, Oprm1
    Ankita Narayan
    Amanda Hunkele
    Jin Xu
    Daniel L. Bassoni
    Gavril W. Pasternak
    Ying-Xian Pan
    Cellular and Molecular Neurobiology, 2021, 41 : 1059 - 1074
  • [3] Mu Opioids Induce Biased Signaling at the Full-Length Seven Transmembrane C-Terminal Splice Variants of the mu Opioid Receptor Gene,Oprm1
    Narayan, Ankita
    Hunkle, Amanda
    Xu, Jin
    Bassoni, Daniel L.
    Pasternak, Gavril W.
    Pan, Ying-Xian
    CELLULAR AND MOLECULAR NEUROBIOLOGY, 2021, 41 (05) : 1059 - 1074
  • [4] Full-Length L1CAM and Not Its Δ2Δ27 Splice Variant Promotes Metastasis through Induction of Gelatinase Expression
    Hauser, Stephanie
    Bickel, Laura
    Weinspach, Dirk
    Gerg, Michael
    Schaefer, Michael K.
    Pfeifer, Marco
    Hazin, John
    Schelter, Florian
    Weidle, Ulrich H.
    Ramser, Juliane
    Volkmann, Juliane
    Meindl, Alfons
    Schmitt, Manfred
    Schroetzlmair, Florian
    Altevogt, Peter
    Krueger, Achim
    PLOS ONE, 2011, 6 (04):